Voriconazole-Induced Periostitis Mimicking Chronic Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation
Joint Authors
Sweiss, Karen
Oh, Annie
Rondelli, Damiano
Patel, Pritesh
Source
Case Reports in Infectious Diseases
Issue
Vol. 2016, Issue 2016 (31 Dec. 2016), pp.1-3, 3 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2016-06-14
Country of Publication
Egypt
No. of Pages
3
Main Subjects
Abstract EN
Voriconazole is an established first-line agent for treatment of invasive fungal infections in patients undergoing allogeneic stem cell transplantation (ASCT).
It is associated with the uncommon complication of periostitis.
We report this complication in a 58-year-old female undergoing HSCT.
She was treated with corticosteroids with minimal improvement.
The symptoms related to periostitis can mimic chronic graft-versus-host disease in patients undergoing HSCT and clinicians should differentiate this from other diagnoses and promptly discontinue therapy.
American Psychological Association (APA)
Sweiss, Karen& Oh, Annie& Rondelli, Damiano& Patel, Pritesh. 2016. Voriconazole-Induced Periostitis Mimicking Chronic Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation. Case Reports in Infectious Diseases،Vol. 2016, no. 2016, pp.1-3.
https://search.emarefa.net/detail/BIM-1100963
Modern Language Association (MLA)
Sweiss, Karen…[et al.]. Voriconazole-Induced Periostitis Mimicking Chronic Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation. Case Reports in Infectious Diseases No. 2016 (2016), pp.1-3.
https://search.emarefa.net/detail/BIM-1100963
American Medical Association (AMA)
Sweiss, Karen& Oh, Annie& Rondelli, Damiano& Patel, Pritesh. Voriconazole-Induced Periostitis Mimicking Chronic Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation. Case Reports in Infectious Diseases. 2016. Vol. 2016, no. 2016, pp.1-3.
https://search.emarefa.net/detail/BIM-1100963
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1100963
